Neil Exter, Partner, Third Rock Ventures, joined Third Rock Ventures in 2007 and has more than 20 years of business development and strategic experience across the spectrum of newly emerging and established biotechnology companies.
Prior to joining Third Rock, Neil was Chief Business Officer of Alantos Pharmaceuticals, leading the sale of the company to Amgen, and earlier, served as vice president for Millennium Pharmaceuticals, directing in-licensing and M&A. Earlier in his career, Neil held various executive and senior management roles within the high technology industry, including tenures at Hewlett Packard and Wang Laboratories.
Neil holds an M.B.A. as a Baker Scholar from Harvard Business School, an M.S. from Stanford University, and a B.S. from Cornell University. He is a member of the Research Committee of Children’s Hospital Boston, a member of the investment committee of the Innovation Research Fund and Innovation Advisory Board at Partners Healthcare, and the treasurer and a member of the board of directors of the New England Venture Capital Association. In addition, Neil serves as a member of the Advisory Council of the Electrical and Computer Engineering Department at Cornell University and the board of visitors of Columbia College.